3 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
Follow Fampridine: new trials by email Literature Review of Fampridine trials Research Report on Fampridine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Effectiveness of Fampridine in Improving Upper Limb Function in MS Fampridine, Placebo - Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis | Phase 4 | Completed | University College Dublin | 64 | 2014-02-21 | 2021-07-09 |
| Short and Long Term Multiple Outcomes in Persons With Multiple Sclerosis Treated by Fampridine. Fampridine - Multiple Sclerosis | Phase 4 | Completed | Centre Hospitalier Universitaire de Besancon | 89 | 2014-02-04 | 2021-02-02 |
| Open-Label Study to Assess the Effect of Long-Term Prolonged-Release Fampridine (BIIB041) on Quality of Life as Reported by Participants With Multiple Sclerosis Fampridine - Multiple Sclerosis | Phase 4 | Completed | Biogen | 901 | 2012-02-01 | 2017-03-21 |
Multiple Sclerosis (3) · Fatigue (1) · Multiple Sclerosis, Chronic Progressive (1)
Biogen (1) · Centre Hospitalier Universitaire de Besancon (1) · University College Dublin (1)
France (2) · Australia (1) · Belgium (1) · Denmark (1) · Germany (1) · Ireland (1) · Italy (1) · Netherlands (1) · Portugal (1) · United Kingdom (1)
PMID 12525714, PMID 14606742, PMID 15147583, PMID 16283615, PMID 16980142, PMID 17895294, PMID 17942508, PMID 18653737, PMID 18951800, PMID 19068404, PMID 1992392, PMID 20594850, PMID 20976768, PMID 21112438, PMID 22315143, PMID 23247892, PMID 23535489, PMID 23791482, PMID 23962697, PMID 24090757, PMID 24378281, PMID 24503204, PMID 25583832, PMID 26041616, PMID 26409700, PMID 26810506, PMID 26843986, PMID 27004639, PMID 32634812, PMID 8148458, PMID 8664723